Tobacco Cessation Treatment Preferences Among Veteran Smokers

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 2, 2022

Primary Completion Date

September 27, 2023

Study Completion Date

September 27, 2023

Conditions
Tobacco Use
Interventions
BEHAVIORAL

Personalized Smoking Cessation Facilitation Meetings

Participants will participate in 5-7 meetings in which they will receive cognitive-behavioral therapy for tobacco cessation.

DRUG

Personalized Smoking Cessation Pharmacotherapy

Participants may receive pharmacotherapy for smoking cessation based on VA Pharmacy Benefits Management Services guidelines. Medications may include nicotine-replacement therapy, varenicline, and/or bupropion.

BEHAVIORAL

Personalized Text Messaging Support

If the participant has a working cell phone and is willing to receive text messages, supportive, personalized text messages will be sent to the participant starting after Session 1 and extending through 6 months post-quit using VA's Annie texting capability.

BEHAVIORAL

SmokefreeVET

Participants will receive a referral to SmokefreeVET, a text-messaging intervention designed to help veterans prepare for and attempt quitting smoking.

BEHAVIORAL

VA Quitline

Participants will receive a referral to VA Quitline, which is a nationally available telehealth intervention that provides assistance to veterans who wish to quit tobacco use. Quitline includes five sessions of cognitive-behavioral treatment.

OTHER

Education about pharmacotherapy

Participants will receive a handout that provides them with information about pharmacotherapies for tobacco cessation.

Trial Locations (1)

27705-3875

Durham VA Medical Center, Durham, NC, Durham

All Listed Sponsors
lead

VA Office of Research and Development

FED